Komori
Gmo Prime Strategy (5250) · RiskDropped

Impact of COVID-19 on Orders, Sales and Profit

First written in FY2022. 1 of 3 entries say "Softened", first in FY2023. Latest entry: FY2024.

3entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022SoftenedFY20232023: 120232024: 120242025: 12025
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report
    The business and other risks for the fiscal year ended November 2024 do not identify the impact of COVID-19 on orders, sales and profit as a standalone risk.
  2. FY2023SoftenedAnnual report

    「During the fiscal year, Japan's economy remained in a challenging environment, with growth limited to a moderate pace. While the social impact of COVID-19 diminished, personal consumption remained sluggish due to high prices, and weakness emerged in machinery investment, particularly in the manufacturing sector, as well as in capital investment, another pillar of domestic demand.」

    The disclosure now states that the social impact of COVID-19 is diminishing, reducing its emphasis from the former standalone risk disclosure.
  3. FY2022First statedAnnual report

    「Cancellations of the Group's services resulting from deterioration in customers' profitability (although not all cancellations are attributable to COVID-19, the company recognises that a certain number of cancellations have continued among smaller customers and others).」

    While recognising a certain number of cancellations among smaller customers and others, the company determined that operations remained at approximately normal levels during the fiscal year and that there was no material accounting impact as of the current date.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Gmo Prime Strategy yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 on Orders, Sales and Profit | GMO PRIME STRATEGY CO.,LTD. (5250) | Komori